At a glance
ClinicalIndex Comparison RecordN/ACompleted· 285 enrolled
Drug / intervention
Micra Pacemaker Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medtronic Micra Transcatheter Pacing System Continued Access Study
In Brief
A clinical study evaluating Micra Pacemaker Implant for Bradycardia. Completed, enrolled 285 participants across 29 sites.
Detailed Summary
Medtronic is sponsoring the Micra Continued Access (CA) study to provide continued access to the Micra System while the marketing application is under review by the Food and Drug Administration (FDA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBradycardia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedJul 2015
Primary CompletionJul 2016
TodayJul 2026
First PostedJul 2, 2015
Enrollment StartJun 1, 2015
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 11 years ago
Interventions
Micra Pacemaker Implantdevice